Centro DE INVESTIGACIÓN BIOMÉDICA EN RED
USPTO PatentsView assignee record - 16 granted patents across 19 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Centro ranks #17,546 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 19 technology areas.
- #17,546
- of 49,997 US assignees by volume
- Top 45%
- by Innovation Score (36.9/100)
- 11.6
- avg claims per patent
- +100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R17546 · Foreign Corporation #17,546 · 16 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 16 grants
- MID-PACK #17,546/49,997
- PHOTO-FINISH Cc3d
- CPC-FOCUS A61P · 19 areas
- INNOV-THIN 36.9/100
- CLAIMS-PAR 11.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Cc3d LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Centro’s 36.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Centro
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Centro DE INVESTIGAC… · this assignee
Centro DE INVESTIGAC… · this assignee
37 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Centro's Innovation Score is 36.9/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Centro?
Each dot is one of Centro’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Centro’s own 11.6 claims/patent is at or below the 16.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Centro's grants concentrate
Centro DE INVESTIGACIÓN BIOMÉDICA EN RED is a focused PatentsView assignee: 19 CPC subclasses with 50% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2018. By volume, Centro sits between Cc3d LLC and Chengdu Image Design Technology Co. Ltd..
Centro's three-year grant acceleration
Centro DE INVESTIGACIÓN BIOMÉDICA EN RED shows 5 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Centro's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Cc3d
Cc3d LLC
16 patents
- CDA Research Group
CDA Research Group, Inc.
16 patents
- Cemco
Cemco, LLC
16 patents
- Central Michigan…
Central Michigan University
16 patents
- Chang WAH Technol…
Chang WAH Technology Co., Ltd.
16 patents
- Check-cap
Check-cap Ltd.
16 patents
- Cheng Shin Rubber…
Cheng Shin Rubber IND. Co., Ltd.
16 patents
- Chengdu Image Des…
Chengdu Image Design Technology Co. Ltd.
16 patents
- Centro DE Investi… ◀
Centro DE INVESTIGACIÓN BIOMÉDICA EN RED
16 patents
What this shows Centro holds 16 patents at rank #17,537, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Centro
By rank, the assignees closest to #17,537 in granted patent volume.
- Cc3d LLC #17,533 · 16 patents
- CDA Research Group, Inc. #17,534 · 16 patents
- Cemco, LLC #17,535 · 16 patents
- Central Michigan University #17,536 · 16 patents
- Chang WAH Technology Co., Ltd. #17,538 · 16 patents
- Check-cap Ltd. #17,539 · 16 patents
- Cheng Shin Rubber IND. Co., Ltd. #17,540 · 16 patents
- Chengdu Image Design Technology Co. Ltd. #17,541 · 16 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Centro's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Centro's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
37 Top 45% higher than 55% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 12.5% |
| 2018 | 1 | 6.3% |
| 2019 | 2 | 12.5% |
| 2020 | 1 | 6.3% |
| 2021 | 4 | 25.0% |
| 2022 | 3 | 18.8% |
| 2023 | 1 | 6.3% |
| 2024 | 1 | 6.3% |
| 2025partial year | 1 | 6.3% |
Which technologies does Centro DE INVESTIGACIÓN BIOMÉDICA EN RED patent most?
Top 15 of 19 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Centro DE INVESTIGACIÓN BIOMÉDICA EN RED's patent record in context - here's where to go next.
- Centro DE INVESTIGACIÓN BIOMÉDICA EN RED's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 50% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #17,546 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Centro DE INVESTIGACIÓN BIOMÉDICA EN RED against Cc3d LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 36.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.